Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02718378 | Evaluation of Safety and Efficacy of Estetrol in Healthy Men | completed | Phase 1 | 45 | Pantarhei Oncology B.V.OTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT02198859 | Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer | completed | Phase 1 | 11 | University of Kansas Medical CenterOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC) |
| completed |
| Phase 1 / Phase 2 |
| 70 |
| BayerINDUSTRY |
| 2 |
| Jan 4, 2017 |
| clinicaltrials |
| NCT01347788 | Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer | completed | Phase 1 | 34 | Massachusetts General HospitalOTHER | 1 | Nov 28, 2016 | clinicaltrials |
| NCT00946309 | Effects of Sulforaphane on Normal Prostate Tissue(PHASE) | completed | Phase 1 / Phase 2 | 45 | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 15, 2016 | clinicaltrials |
| NCT01565746 | Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese Patients | completed | Phase 1 | 19 | BayerINDUSTRY | 1 | Oct 17, 2016 | clinicaltrials |
| NCT01283373 | A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 84 | Genentech, Inc.INDUSTRY | 1 | Oct 4, 2016 | clinicaltrials |
| NCT01522820 | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors | completed | Phase 1 | 18 | Roswell Park Cancer InstituteOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00852007 | A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1(MUC1) | completed | Phase 1 / Phase 2 | 20 | Hamilton Health Sciences CorporationOTHER | 1 | Sep 15, 2016 | clinicaltrials |
| NCT00588640 | Study of D-Methadone in Patients With Chronic Pain | completed | Phase 1 / Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT01511536 | Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer | completed | Phase 1 / Phase 2 | 38 | SanofiINDUSTRY | 3 | Jul 28, 2016 | clinicaltrials |
| NCT00374049 | MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer | completed | Phase 1 | 14 | Olivera FinnOTHER | 1 | Jul 12, 2016 | clinicaltrials |
| NCT00676286 | Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers | completed | Phase 1 | 26 | AHS Cancer Control AlbertaOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT01155258 | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | Jun 13, 2016 | clinicaltrials |
| NCT02093390 | A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects | completed | Phase 1 | 40 | Millennium Pharmaceuticals, Inc.INDUSTRY | 0 | Jun 6, 2016 | clinicaltrials |
| NCT00943956 | Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer | completed | Phase 1 | 30 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | May 25, 2016 | clinicaltrials |
| NCT00459186 | The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer | completed | Phase 1 / Phase 2 | 19 | Dana-Farber Cancer InstituteOTHER | 1 | May 16, 2016 | clinicaltrials |
| NCT01378091 | Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer | completed | Phase 1 | 64 | Columbia UniversityOTHER | 1 | May 9, 2016 | clinicaltrials |
| NCT01219790 | ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma(GEMO) | completed | Phase 1 | 30 | Institut Cancerologie de l'OuestOTHER | 1 | Apr 19, 2016 | clinicaltrials |
| NCT00345293 | Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer | completed | Phase 1 / Phase 2 | 13 | Rockefeller UniversityOTHER | 1 | Apr 18, 2016 | clinicaltrials |
| NCT00569153 | Safety Study of TAK-700 in Subjects With Prostate Cancer.(TAK-700) | completed | Phase 1 / Phase 2 | 123 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 4, 2016 | clinicaltrials |
| NCT00811265 | Safety Evaluation of ExAblate MRgFUS for Prostate Cancer | completed | Phase 1 | 10 | InSightecINDUSTRY | 1 | Mar 8, 2016 | clinicaltrials |
| NCT02020291 | Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer | completed | Phase 1 | 31 | WntResearch ABINDUSTRY | 1 | Feb 2, 2016 | clinicaltrials |
| NCT01206036 | CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)(CEPTAS) | completed | Phase 1 / Phase 2 | 19 | Central European Society for Anticancer Drug ResearchOTHER | 1 | Jan 27, 2016 | clinicaltrials |
| NCT00085566 | Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | 61 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Jan 20, 2016 | clinicaltrials |
| NCT00987376 | Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration | completed | Phase 1 | 8 | Mayo ClinicOTHER | 1 | Jan 13, 2016 | clinicaltrials |
| NCT01162395 | Open Label Prostate Cancer Study | completed | Phase 1 | 64 | AstraZenecaINDUSTRY | 3 | Jan 12, 2016 | clinicaltrials |
| NCT00604526 | High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy | completed | Phase 1 | 42 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT00581815 | Spectroscopy With Surface Coils and Decoupling | completed | Phase 1 | 582 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT02057237 | A Safety and Feasibility Study of Mitotane in Prostate Cancer | completed | Phase 1 | 1 | University Health Network, TorontoOTHER | 1 | Dec 17, 2015 | clinicaltrials |
| NCT01095848 | A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer | completed | Phase 1 | 23 | ImmunoVaccine Technologies, Inc. (IMV Inc.)INDUSTRY | 1 | Dec 15, 2015 | clinicaltrials |
| NCT00667537 | PK in Pts With HRPC & Skeletal Metastes | completed | Phase 1 | 6 | BayerINDUSTRY | 1 | Dec 14, 2015 | clinicaltrials |
| NCT00652210 | Use of Multiphoton Microscopy in the Diagnosis of Cancer(MPM) | completed | Phase 1 | 344 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 10, 2015 | clinicaltrials |
| NCT00450229 | Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Dec 4, 2015 | clinicaltrials |
| NCT01172028 | Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | University of ArizonaOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT01261754 | A Study of 99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients With Metastatic Prostate Adenocarcinoma and Healthy Volunteers | completed | Phase 1 | 16 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2015 | clinicaltrials |
| NCT01572701 | Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection | completed | Phase 1 | 8 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2015 | clinicaltrials |
| NCT01615406 | A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer | completed | Phase 1 | 9 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2015 | clinicaltrials |
| NCT01654874 | 99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404 | completed | Phase 1 | 6 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2015 | clinicaltrials |
| NCT00928174 | Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer | completed | Phase 1 / Phase 2 | 27 | Queen's Medical CenterOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT00872157 | BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets | completed | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 23, 2015 | clinicaltrials |
| NCT01229618 | Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer | completed | Phase 1 | 31 | University of California, San FranciscoOTHER | 1 | Oct 5, 2015 | clinicaltrials |
| NCT02338700 | Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma Patient | completed | Phase 1 / Phase 2 | 20 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 10, 2015 | clinicaltrials |
| NCT02437539 | Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography(uPAR-PET) | completed | Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Aug 24, 2015 | clinicaltrials |
| NCT01897207 | Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer | completed | Phase 1 / Phase 2 | 15 | Cantonal Hospital of St. GallenOTHER | 0 | Aug 17, 2015 | clinicaltrials |
| NCT00514267 | An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors | completed | Phase 1 / Phase 2 | 32 | Astellas Pharma IncINDUSTRY | 1 | Aug 13, 2015 | clinicaltrials |
| NCT00250224 | Prostate Localization During Radiotherapy Using a Ni-Ti Stent and Electronic Portal Imaging - Protocol II | completed | Phase 1 | 100 | Aalborg University HospitalOTHER | 1 | Jun 26, 2015 | clinicaltrials |
| NCT00327288 | Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients | completed | Phase 1 | 34 | AmpliMed CorporationINDUSTRY | 1 | Jun 24, 2015 | clinicaltrials |
| NCT00178113 | A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia | completed | Phase 1 | 80 | University of PittsburghOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT00743379 | Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 71 | Threshold PharmaceuticalsINDUSTRY | 1 | May 7, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Feb 9, 2017source: clinicaltrials